FERGENE
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals. has been created to potentially commercialize nadofaragne firadenovec in the US and to advance the global clinical development.
FERGENE
Industry:
Genetics Health Care Life Science Therapeutics
Founded:
2019-11-01
Address:
Saint-prex, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.fergene.com
Total Employee:
1+
Status:
Active
Total Funding:
570 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content
Similar Organizations
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Mogrify
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Ferring Pharmaceuticals
Ferring Pharmaceuticals investment in Private Equity Round - FerGene
Blackstone Group
Blackstone Group investment in Private Equity Round - FerGene
Official Site Inspections
http://www.fergene.com
- Host name: ec2-54-157-108-158.compute-1.amazonaws.com
- IP address: 54.157.108.158
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "FerGene"
FerGene - Crunchbase Company Profile & Funding
Organization. FerGene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals. Saint-prex, Vaud, …See details»
FerGene - LinkedIn
FerGene is a new gene therapy company dedicated to creating and delivering innovative solutions to urologists and those affected by non-muscle invasive bladder cancer (NMIBC).See details»
FerGene Company Profile 2024: Valuation, Investors, Acquisition
FerGene General Information Description. Developer of gene therapy treatment designed to create and deliver innovative treatments for bladder cancer. The company's treatment aims to …See details»
FerGene - Contacts, Employees, Board Members, Advisors & Alumni
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals.See details»
FerGene - Products, Competitors, Financials, Employees, …
FerGene is a gene therapy company operating in the healthcare sector, with a specific focus on urology and bladder cancer. The company's main offering is the development and delivery of …See details»
Blackstone and Ferring pump $570m into bladder cancer gene …
Nov 26, 2019 The deal will see the creation of a new company called FerGene, focused on the global development and marketing of nadofaragene firadenovec, intended for patients with …See details»
FerGene Appoints Top Biotech Leaders to Executive Team
Jun 17, 2020 About FerGene FerGene is a gene therapy company committed to revolutionizing the treatment of bladder cancer through its innovative science and unparalleled commitment to …See details»
FerGene - Funding, Financials, Valuation & Investors - Crunchbase
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... How …See details»
Ferring, Blackstone spin out gene therapy with $570M in funding
Nov 25, 2019 The result is FerGene, a spinout that is starting life with $400 million from Blackstone and up to $170 million from Ferring. FerGene will use some of the money to …See details»
FerGene gene therapy firm formed with $570 million in funding
Nov 30, 2019 FerGene has launched with more than $570 million in funding from Ferring Pharmaceuticals and Blackstone Life Sciences to bring to market nadofaragene firadenovec, a …See details»
Landmark Study in Non-Muscle Invasive Bladder Cancer
Nov 30, 2020 “Our organization is proud to have played a key role in the mid- and late-stage clinical studies for nadofaragene firadenovec.” ... About FerGene Inc. FerGene Inc. is a gene …See details»
Revolutionizing the treatment of bladder cancer - Nature
Gene therapy company FerGene Inc. is developing products for the treatment of urologic cancers, the company’s lead product, nadofaragene firadenovec, uses a non-replicating adenovirus …See details»
Ferring and Blackstone Life Sciences Invest Over $570 Million USD …
Nov 25, 2019 FerGene’s goal is to bring this promising therapy to a patient population which has seen little improvement in their standard of care over the past twenty years. Blackstone will …See details»
FerGene Appoints Top Biotech Leaders to Executive Team
Jun 17, 2020 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- FerGene, Inc., a privately held gene therapy company dedicated to revolutionizing the treatment of bladder cancer, today …See details»
Ferring, Blackstone form FerGene | C&EN Global Enterprise
Dec 2, 2019 FerGene has launched with more than $570 million in funding from Ferring Pharmaceuticals and Blackstone Life Sciences to bring to market nadofaragene firadenovec, a …See details»
Building Our Future at FerGene - LinkedIn
Jun 23, 2020 As the Chief Operating Officer for FerGene, I oversee the commercial organization consisting of sales and marketing, communications and advocacy, analytics, business …See details»
Ferring and Blackstone Life Sciences Invest Over $570 Million USD …
Nov 25, 2019 Ferring launches new company FerGene, with a focus on the global development and US commercialization of nadofaragene firadenovec, for high-grade, Bacillus Calmette …See details»
FerGene to Present Bladder Cancer Data at - Business Wire
Feb 10, 2020 FerGene, a newly created gene therapy company committed to revolutionizing the treatment of bladder cancer, today announced it will present research a. FerGene, a newly …See details»
FerGene announces pivotal Phase 3 study of ... - Ferring Global
Dec 5, 2019 Washington D.C, US – December 5, 2019. FerGene, a new gene therapy company formed by Ferring Pharmaceuticals and Blackstone Life Sciences, announced today positive …See details»
Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating ...
Nov 30, 2020 “Our organization is proud to have played a key role in the mid- and late-stage ... FerGene Inc. is a gene therapy company committed to revolutionizing the treatment of bladder …See details»